Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqCM - Delayed Quote USD

Nutriband Inc. (NTRBW)

Compare
3.1000
-0.0700
(-2.21%)
At close: 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Total Revenue
2,021.7710
2,085.3140
2,079.6090
1,422.1540
943.7020
Cost of Revenue
1,383.1700
1,223.2090
1,329.2000
917.8440
627.3780
Gross Profit
638.6010
862.1050
750.4090
504.3100
316.3240
Operating Expense
6,671.0100
5,734.0310
4,898.2680
4,434.2070
2,912.2690
Operating Income
-6,032.4090
-4,871.9260
-4,147.8590
-3,929.8970
-2,595.9450
Net Non Operating Interest Income Expense
107.7230
-58.9650
-8.2890
-118.4210
-349.8170
Other Income Expense
--
-554.4230
-327.3260
-2,127.8080
12.9340
Pretax Income
-6,847.1450
-5,485.3140
-4,483.4740
-6,176.1260
-2,932.8280
Net Income Common Stockholders
-6,847.1450
-5,485.3140
-4,483.4740
-6,372.7150
-2,932.8280
Diluted NI Available to Com Stockholders
-6,847.1450
-5,485.3140
-4,483.4740
-6,372.7150
-2,932.8280
Total Operating Income as Reported
-6,032.4090
-4,871.9260
-4,475.1850
-6,110.7330
-2,595.9450
Total Expenses
8,054.1800
6,957.2400
6,227.4680
5,352.0510
3,539.6470
Net Income from Continuing & Discontinued Operation
-6,847.1450
-5,485.3140
-4,483.4740
-6,176.1260
-2,932.8280
Normalized Income
-5,924.6860
-4,930.8910
-4,156.1480
-4,048.3180
-2,945.7620
Interest Income
148.6050
16.8500
--
--
--
Interest Expense
40.8820
75.8150
8.2890
118.4210
280.6860
Net Interest Income
107.7230
-58.9650
-8.2890
-118.4210
-349.8170
EBIT
-6,806.2630
-5,409.4990
-4,475.1850
-6,057.7050
-2,652.1420
EBITDA
-6,524.7240
-5,121.7770
-4,145.0420
-5,739.4420
-2,482.4240
Reconciled Cost of Revenue
1,383.1700
1,223.2090
1,329.2000
917.8440
627.3780
Reconciled Depreciation
281.5390
287.7220
330.1430
318.2630
169.7180
Net Income from Continuing Operation Net Minority Interest
-6,847.1450
-5,485.3140
-4,483.4740
-6,176.1260
-2,932.8280
Total Unusual Items Excluding Goodwill
-922.4590
-554.4230
-327.3260
-2,127.8080
12.9340
Total Unusual Items
-922.4590
-554.4230
-327.3260
-2,127.8080
12.9340
Normalized EBITDA
-5,602.2650
-4,567.3540
-3,817.7160
-3,611.6340
-2,495.3580
1/31/2021 - 10/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OMGAQ
0.0309
-0.38%
 
RADX Radiopharm Theranostics Limited
5.0000
-5.84%
 
NBY NovaBay Pharmaceuticals, Inc.
0.6050
-0.84%
 
ELTX Elicio Therapeutics, Inc.
8.31
+0.48%
 
APRE Aprea Therapeutics, Inc.
2.5336
+0.14%
 
ADXN Addex Therapeutics Ltd
8.50
+0.59%
 
ACTU Actuate Therapeutics, Inc. Common stock
7.24
+4.47%
 
OXB.L Oxford Biomedica plc
330.00
+0.61%
 
KTTA Pasithea Therapeutics Corp.
1.1600
-4.92%
 
INKT MiNK Therapeutics, Inc.
8.95
-2.72%